Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid

Lasers in Surgery and Medicine

Volumn 30, Issue 4, 2002, Pages 273-279

  Fehr, Mathias K ^a   Hornung, Ren ^a   Degen, Andrea ^a   Schwarz, Viola A ^a   Fink, Daniel ^a   Haller, Urs ^a   Wyss, Pius ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Laser evaporation; Photodynamic therapy; Vagina; Vulva; Vulvar intraepithelial neoplasia

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CARBON DIOXIDE LASER; CARCINOMA IN SITU; CLINICAL ARTICLE; CONDYLOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LASER EVAPORATION; LASER SURGERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SURVIVAL RATE; TISSUE REPAIR; TREATMENT OUTCOME; VAGINA DISEASE; VULVA DISEASE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AMINOLEVULINIC ACID; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; LASER SURGERY; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; VAGINAL DISEASES; VAGINAL NEOPLASMS; VULVAR DISEASES; VULVAR NEOPLASMS;

EID: 0036231747     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10048     Document Type: Article

References (38)

1. STD Treatment Guidelines
2. Genitalwarts - A veneral disease
3. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelialneoplasia
4. Possible etiologic heterogeneity of vulvar intraepithelial neoplasia. A correlation of pathologic characteristics with human papillomavirus detection by in situ hybridization and polymerase chain reaction
5. Sexually transmitted infection as a cause of anal cancer
6. Vulvar intraepithelial neoplasia III: A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma
7. Trends in squamous cell carcinoma of the vulva: The influence of vulvar intraepithelial neoplasia
8. Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva
9. Intraepithelial and invasive squamous cell neoplasia of the vulva: Trends in incidence, recurrence, and survival rate in Norway
10. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy
11. Definition of type I and type II photosensitized oxidation
12. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence
13. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience
14. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy
15. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
16. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease
17. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: Randomised double-blind trial
18. Photodynamic treatment for lower genital tract intraepithelial neoplasia
19. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid
20. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid
21. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid
22. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: Implications for photodynamic treatment
23. Superficial laser vulvectomy. II. The anatomic and biophysical principles permitting accurate control over the depth of dermal destruction with the carbon dioxide laser
24. Superficial laser vulvectomy. IV. Extended laser vaporization and adjunctive 5-fluorouracil therapy of human papillomavirus-associated vulvar disease
25. Differential cell death response to photodynamic therapy is dependent on dose and cell type
26. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy
27. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy
28. 2 laser for the treatment of vulvar carcinoma in situ
29. Treatment of condylomata acuminata: Efficacy of the carbon dioxide laser
30. Clinical experiences with photodynamic therapy for recurrent malignancies of the lower female genital tract
31. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: A pilot study
32. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
33. Risk factors for recurrent VIN. Role of multifocality and grade of disease
34. Vulvar intraepithelial neoplasia III: Occult cancer and the impact of margin status on recurrence
35. Vulvar intraepithelial neoplasia III: A viral disease of undetermined progressive potential
36. Laser surgery for vulvar intraepithelial neoplasia: Principles and results
37. Prognosis of vulvar dysplasia and carcinoma in situ with special reference to histology and types of human papillomavirus (HPV)
38. Structural and functional effects of endometrial photodynamic therapy in a rat model